Innovative RF solid state amplifiers at IPAC
After another successful participation last year, West London based microwave and RF manufacturer TMD Technologies Limited (TMD will be attending this year’s International Particle Accelerator Conference (IPAC2019) in Melbourne, showing new products for mainstream science.
TMD is set to participate again in the International Particle Accelerator Conference as it is the key accelerator event. With an estimated 1,000 delegates this year, IPAC is the ultimate event for meeting and networking with the elite in the professional accelerator community and industry worldwide.
TMD’s modular architecture, solid state RF amplifiers employ innovative power combining methods to provide many user benefits.
The amplifiers are typically based on one 19” rack/100kW (pulse), with frequencies available from 20MHz to 1.3GHz. Operating as CW or pulse systems (with long pulse systems available) they have a wall plug efficiency competitive with tube technology.
These highly efficient amplifiers are robustly resistant to VSWR mismatch, are easily maintainable with ‘hot swap’ availability, and exhibit no loss of power from any single element failure. They can be combined to provide MW power capability.
TMD’s extensive portfolio includes high power, very low phase noise travelling wave tube (TWT) amplifiers, brazed UHV components, and electron guns.
Richard Patrick, TMD’s Head of Business Development, said: “Our collaboration with the Rosatom-NIITFA organisation has enabled us to offer a wide range of solid state amplifiers that are revolutionary in design, and now available to customers. The first units have already been fielded and operated successfully at customers’ premises.”
“With a host of advanced features, including hot swap for both RF modules and DC Power Supplies to maximise system availability, these amplifiers are ideal for many applications, including tetrode amplifier replacement; synchrotrons; LINACs for scientific, experimentation/particle physics and spallation systems; medical therapy equipment; and cyclotrons for radioisotope production, with the ability to upgrade existing systems.”